Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis

Currently, limited information is available to clinicians regarding the long-term efficacy of omalizumab treatment for allergic asthma. In this report, we aimed to (i) systematically review the evidence regarding the long-term efficacy of omalizumab in patients with persistent uncontrolled allergic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Tianwen, Wang, Shaobin, Xu, Zhiwei, Zhang, Chao, Zhao, Yun, Hu, Yue, Cao, Chao, Ying, Songmin, Chen, Zhihua, Li, Wen, Wu, Bin, Shen, Huahao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314644/
https://www.ncbi.nlm.nih.gov/pubmed/25645133
http://dx.doi.org/10.1038/srep08191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314644/
https://www.ncbi.nlm.nih.gov/pubmed/25645133
http://dx.doi.org/10.1038/srep08191

Ejemplares similares